ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Air Canada sells 25% stake in Aeroplan for $2.5 bln

Transaction values Aeroplan at $10 billion as airline monetizes loyalty program amid recovery. Proceeds to reduce debt and support liquidity.

PA
Priya Anand · Equities & Earnings Desk · 14 Aug 2026 · 1 min read
Share
Air Canada sells 25% stake in Aeroplan for $2.5 bln

Air Canada announced the sale of a 25% stake in its Aeroplan loyalty program to a consortium of investors for $2.5 billion, valuing the unit at $10 billion.

The transaction, structured as a secondary offering, includes commitments from existing shareholders TD Bank Group and Aimia Inc., which will maintain their combined 17% ownership. Air Canada will retain majority control with a 58% stake in Aeroplan, a unit it spun off in 2020.

Proceeds from the sale will be used to reduce debt and bolster liquidity, the airline said. Aeroplan operates one of Canada’s largest loyalty programs, with over 5 million active members and partnerships spanning retail, financial services, and travel sectors.

The deal underscores Air Canada’s strategy to monetize non-core assets while maintaining operational control. The airline has faced financial strain from the pandemic but reported improving cash flows in recent quarters amid a rebound in travel demand.

Analysts noted the valuation reflects Aeroplan’s strong recurring revenue model and diversified partnerships, though the airline’s leverage remains a key focus for investors. Air Canada’s debt stood at approximately $4.5 billion as of its last quarterly filings.

The transaction is expected to close in the second half of 2024, subject to regulatory approvals.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT